The Library
PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights
Tools
Ryan, Sinéad M., Frías, Jesús M., Wang, Xuexuan, Sayers, Claire T., Haddleton, David M. and Brayden, David J. (2011) PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights. Journal of Controlled Release, Vol.149 (No.2). pp. 126-132. doi:10.1016/j.jconrel.2010.10.004 ISSN 01683659.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.jconrel.2010.10.004
Abstract
Salmon calcitonin (sCT) was conjugated via cysteine-1 to novel comb-shaped end-functionalised (poly(PEG) methyl ether methacrylate) (sCT-P) polymers, to yield conjugates of total molecular weights (MW) inclusive of sCT: 6.5, 9.5, 23 and 40 kDa. The conjugates were characterised by HPLC and their in vitro and in vivo bioactivity was measured by cAMP assay on human T47D cells and following intravenous (i.v.) injection to rats, respectively. Stability against endopeptidases, rat serum and liver homogenates was assessed. There were linear and exponential relationships between conjugate MW with potency and efficacy respectively, however the largest MW conjugate still retained 70% of Emax and an EC50 of 3.7 nM. In vivo, while free sCT and the conjugates reduced serum [calcium] to a maximum of 15–30% over 240 min, the half-life (T1/2) was increased and the area under the curve (AUC) was extended in proportion to conjugate MW. Likewise, the polymer conferred protection on sCT against attack by trypsin, chymotrypsin, elastase, rat serum and liver homogenates, with the best protection afforded by sCT-P (40 kDa). Mathematical modelling accurately predicted the MW relationships to in vitro efficacy, potency, in vivo PK and enzymatic stability. With a significant increase in T1/2 for sCT, the 40 kDa MW comb-shaped PEG conjugate of sCT may have potential as a long-acting injectable formulation.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology |
||||
Divisions: | Faculty of Science, Engineering and Medicine > Science > Chemistry | ||||
Library of Congress Subject Headings (LCSH): | Pharmacokinetics, Bioconjugates, Osteoporosis, Polymers | ||||
Journal or Publication Title: | Journal of Controlled Release | ||||
Publisher: | Elsevier BV | ||||
ISSN: | 01683659 | ||||
Official Date: | January 2011 | ||||
Dates: |
|
||||
Volume: | Vol.149 | ||||
Number: | No.2 | ||||
Page Range: | pp. 126-132 | ||||
DOI: | 10.1016/j.jconrel.2010.10.004 | ||||
Status: | Peer Reviewed | ||||
Access rights to Published version: | Restricted or Subscription Access | ||||
Funder: | Science Foundation Ireland (SFI) | ||||
Grant number: | 07/SRC/B1154 (SFI) |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |